The metabolite BH4 controls T cell proliferation in autoimmunity and cancerShane J. F. Cronin, Josef Penninger, Corey R. Seehus et al.|Nature|2018Cited by 288
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanomaLisa Haas, Anna C. Obenauf, Lukas Leiendecker et al.|Nature Cancer|2021Cited by 196